Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
NASDAQ:HCAT
Holding HCAT?
Track your performance easily
See the Price Targets and Ratings of:
HCAT Analyst Ratings
Moderate Buy
7 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HCAT Stock 12 Month Forecast
Average Price Target
$11.05
▲(55.85% Upside)
| Highest Price Target$14.00 | Average Price Target$11.05 | Lowest Price Target$9.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Assigned
11/26/24
J.P. Morgan
Reiterated
11/20/24
Stephens
Reiterated
11/14/24
Citi
Reiterated
11/13/24
Stifel Nicolaus
Reiterated
11/07/24
Barclays
Reiterated
11/07/24
Evercore ISI
Assigned
11/07/24
Canaccord Genuity
Reiterated
11/06/24
BTIG
Reiterated
11/06/24
RBC Capital
Reiterated
11/06/24
Cantor Fitzgerald
$16
Buy
125.67%
Upside
Reiterated
08/08/24
Cantor Fitzgerald Remains a Buy on Health Catalyst (HCAT)
Wells Fargo
$13
Buy
83.36%
Upside
Reiterated
08/08/24
Analysts Are Bullish on These Healthcare Stocks: Neuren Pharmaceuticals Limited (NURPF), Fisher & Paykel Healthcare Corporation Limited (FSPKF)
KeyBanc
―
Hold
―
Reiterated
05/10/24
KeyBanc Keeps Their Hold Rating on Health Catalyst (HCAT)
Guggenheim
$14
Buy
97.46%
Upside
Upgraded
01/25/24
Analysts Conflicted on These Healthcare Names: Karuna Therapeutics (NASDAQ: KRTX) and Health Catalyst (NASDAQ: HCAT)
Best Analysts Covering Health Catalyst
Which Analyst Should I Follow If I Want to Buy HCAT and Sell After:
1 Month
xxx
Success Rate
11/19 ratings generated profit
Average Return
+3.55%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.89% of your transactions generating a profit, with an average return of +3.55% per trade.
3 Months
xxx
Success Rate
11/19 ratings generated profit
Average Return
+9.37%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.89% of your transactions generating a profit, with an average return of +9.37% per trade.
1 Year
Success Rate
7/19 ratings generated profit
Average Return
-10.38%
reiterated a buy rating 2 months ago
Copying Richard Close's trades and holding each position for 1 Year would result in 36.84% of your transactions generating a profit, with an average return of -10.38% per trade.
2 Years
xxx
Success Rate
5/19 ratings generated profit
Average Return
-33.52%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 26.32% of your transactions generating a profit, with an average return of -33.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HCAT Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
8
11
11
10
5
Buy
2
2
2
3
6
Hold
3
3
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
16
16
16
14
Each month's total comprises the sum of three months' worth of ratings.
HCAT Financial Forecast
HCAT Stock Forecast FAQ
What is HCAT’s average 12-month price target, according to analysts?
Based on analyst ratings, Health Catalyst’s 12-month average price target is $11.05.
What is HCAT’s upside potential, based on the analysts’ average price target?
Health Catalyst has 55.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HCAT a Buy, Sell or Hold?
Health Catalyst has a consensus rating of Moderate Buy which is based on 7 buy ratings, 3 hold ratings and 0 sell ratings.
What is Health Catalyst’s price target?
The average price target for Health Catalyst is $11.05. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $14.00 ,the lowest forecast is $9.00. The average price target represents 55.85% Increase from the current price of $7.09.
The highest analyst price target is $14.00 ,the lowest forecast is $9.00. The average price target represents 55.85% Increase from the current price of $7.09.
What do analysts say about Health Catalyst?
Health Catalyst’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of HCAT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.